Bernardo, Miguel <br/><br/>
Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain.  [electronic resource] 

 -  Clinical drug investigation  2006 
 - 447-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1173-2563 
<br/><br/><label>Standard No.: </label>10.2165/00044011-200626080-00003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--administration & dosage<br/>Chronic Disease<br/>Cost-Benefit Analysis--methods<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Humans<br/>Models, Econometric<br/>Piperazines--administration & dosage<br/>Program Evaluation--methods<br/>Recurrence<br/>Reproducibility of Results<br/>Schizophrenia--economics<br/>Spain<br/>Thiazoles--administration & dosage<br/>Time Factors